Carlsmed reported a gross margin of 76.78% and a net margin of -55.49% for the quarter ended Jun 2026. These financial ratios cover 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||
| Gross Margin | 75.02% | 72.81% | 74.66% | 74.94% | 73.40% | 75.93% | 76.54% | 77.10% | 76.78% |
| EBT Margin | -102.22% | -118.13% | -174.62% | -100.57% | -93.78% | -64.72% | -207.74% | -101.07% | -108.29% |
| EBIT Margin | -103.91% | -118.01% | -49.93% | -56.13% | -53.81% | -69.11% | -61.44% | -57.56% | -58.27% |
| EBITDA Margin | -103.91% | -118.01% | -49.93% | -56.13% | -53.81% | -69.11% | -61.44% | -57.56% | -58.27% |
| Operating Margin | -103.91% | -118.01% | -49.93% | -56.13% | -53.81% | -69.11% | -61.44% | -57.56% | -58.27% |
| Net Margin | -103.22% | -127.54% | -50.17% | -61.96% | -56.00% | -65.21% | -56.80% | -53.96% | -55.49% |
| FCF Margin | -115.81% | -45.32% | -81.56% | -60.39% | -65.92% | -36.05% | -81.50% | -42.16% | |
| Efficiency | |||||||||
| Inventory AverageInventory Avg. | 1.20M | 1.59M | 1.95M | 2.17M | |||||
| Assets AverageAssets Avg. | 94.07M | 132.49M | 124.44M | 118.49M | |||||
| Invested CapitalInvested Cap. | -55.22M | -67.64M | 122.10M | 114.22M | 107.61M | 99.63M | |||
| Asset Utilization RatioAsset Util. | 0.48 | 0.38 | 0.45 | 0.53 | |||||
| Leverage & Solvency | |||||||||
| Interest Coverage RatioInterest Cover | -19.44 | -19.35 | -0.39 | -1.17 | -1.26 | -23.78 | -0.40 | -1.17 | -1.07 |
| Debt Ratio | 0.30 | 0.29 | 0.11 | 0.12 | 0.13 | 0.13 | |||
| Times Interest Earned | -19.44 | -19.35 | -0.39 | -1.17 | -1.26 | -23.78 | -0.40 | -1.17 | -1.07 |
| Valuation | |||||||||
| Price to EarningsP/E | -33.11 | -20.39 | -28.29 | -26.89 | |||||
| Price to SalesP/S | 21.59 | 11.58 | 15.26 | 14.92 | |||||
| Price to BookP/B | 2.65 | 1.78 | 2.67 | 3.35 | |||||
| Enterprise Value | 166.78M | 65.85M | 124.89M | 169.30M | |||||
| EV to EBIT | -18.46 | -7.07 | -13.46 | -15.34 | |||||
| EV to EBITDA | -18.46 | -7.07 | -13.46 | -15.34 | |||||
| Market Capitalization | 282.28M | 175.64M | 245.99M | 282.60M | |||||
| Price to FCFP/FCF | -32.75 | -32.13 | -18.73 | -35.39 | |||||
| EV to FCF | -19.35 | -12.04 | -9.51 | -21.20 | |||||
| EV to CFO | -19.72 | -12.38 | -9.60 | -23.01 | |||||
| Return Ratios | |||||||||
| Return on Sales [ROS]ROS | -103.91% | -118.01% | -49.93% | -56.13% | -53.81% | -69.11% | -61.44% | -57.56% | -58.27% |
| Return on Capital Employed [ROCE]ROCE | -31.22% | -25.86% | -29.75% | -36.45% | |||||
| Return on Assets [ROA]ROA | -49.40% | -46.45% | -54.31% | -64.79% |